$NICE

NICE Ltd.

alphai earnings readQ2 FY2026 · AUG 5NiCE Exceeds Revenue Guidance Range, Reporting 8% Year-Over-Year Revenue Growth in Second Quarter 2026Verdict: mixed

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
0
1

No SEC Form 4 filings for $NICE in the last 30 days.

See all $NICE insider activity →
Low

Wed: TASE gains, lifted by banks and chip cos

The Tel Aviv Stock Exchange rose, with the Tel Aviv 35 Index up 1.30% to 4,201.89 points. Banks and chip companies led gains, while Palo Alto Networks fell 8.39% after earnings. Turnover was NIS 5.12 billion in equities. The shekel strengthened against the dollar and euro.

Fri: Weak defense stocks weigh on indices

Friday on the Tel Aviv Stock Exchange, major indices declined. Tel Aviv 35 fell 0.33% to 4,202.63 and Tel Aviv 125 fell 0.31% to 4,074.63. Defense and renewable energy sector indices dropped, while chemicals rubber and plastics rose. FX rates weakened versus the dollar and euro. Bank Hapoalim rose 0.31%, Tower Semiconductor fell 4.35%, Teva fell 2.28%.

NICE sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning NICE (NICE Ltd.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent NICE coverage spans market movers, earnings and technology.

What's driving NICE

alphai scores every news story that mentions NICE with an AI model for sentiment and relevance, and aggregates insider trades from NICE Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $NICE

Score

Wed: TASE gains, lifted by banks and chip cos

The Tel Aviv Stock Exchange rose, with the Tel Aviv 35 Index up 1.30% to 4,201.89 points. Banks and chip companies led gains, while Palo Alto Networks fell 8.39% after earnings. Turnover was NIS 5.12 billion in equities. The shekel strengthened against the dollar and euro.

Bluecrest Transforms Healthcare Experience with NiCE Copilot, Delivering 94% Call Answer Rate Improvements

NICE (Nasdaq: NICE) said Bluecrest, a UK health intelligence firm, deployed the NiCE CXone platform with SVL Business Solutions to modernize its contact center. The release cites £250,000 annual savings, a 94% call answer rate, 100% interaction analysis, and coaching-driven product conversations rising from 10% to 70%, contributing to 2,200+ subscriptions.

$TSEMLow

Fri: Weak defense stocks weigh on indices

Friday on the Tel Aviv Stock Exchange, major indices declined. Tel Aviv 35 fell 0.33% to 4,202.63 and Tel Aviv 125 fell 0.31% to 4,074.63. Defense and renewable energy sector indices dropped, while chemicals rubber and plastics rose. FX rates weakened versus the dollar and euro. Bank Hapoalim rose 0.31%, Tower Semiconductor fell 4.35%, Teva fell 2.28%.

$NICEHighAI 9/10

NICE (NICE) Q2 2026 Earnings Call Transcript

NICE Ltd. reported Q2 2026 revenue of $782 million, up 8% year over year, and cloud revenue of $609 million, up 12.6%. Non-GAAP EPS was $2.70. Management cited CX AI and self-service ARR of $362 million (+52%), operating margin of 25.3%, and free cash flow of $93 million. Full-year 2026 revenue guidance is $3.170B to $3.190B.

$NICELow

NiCE Publishes 2025 Environmental, Social and Governance (ESG) Report, Demonstrating Commitment to Innovation and Sustainability

NiCE (Nasdaq: NICE) said it published its 2025 ESG report, prepared with reference to GRI 2021 standards. The company reported expanding responsible AI, including the NiCE Cognigy acquisition, and reinvesting 14% of revenue in R&D. It cited a 23% Scope 1 and 2 emissions reduction in 2025, plus workforce and ethics-training initiatives.

$NICEHigh

NICE Ltd. (NICE): Financial results for Q2 2026

NICE Ltd. (NICE) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 NiCE Exceeds Revenue Guidance Range, Reporting 8% Year-Over-Year Revenue Growth in Second Quarter 2026 • Total revenue growth driven by 12.6% year over year cloud revenue growth • International revenue increased 22% year over year (21% in constant currency) • Company

$TEVAMed

Wed: Teva jumps but TASE continues to lose ground

Globes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.

RBC Capital Keeps Their Buy Rating on NICE (NICE)

RBC Capital analyst Rishi Jaluria reiterated a Buy rating on NICE on July 26 and set a $130.00 price target. The article cites TipRanks data on Jaluria’s track record. It also notes Rosenblatt kept a Buy on July 21, while Morgan Stanley downgraded NICE to Hold the same day. NICE reported $766.53M revenue and $46.69M net profit for the quarter ended March 31.

$TSEMLow

Mon: Chip cos lead sharp falls

Israel stocks fell on Monday. The Tel Aviv 35 Index dropped 2.15% to 4,161.81 and the Tel Aviv 125 Index fell 1.87% to 4,095.62. Chip-related shares led declines: Tower Semiconductor fell 14.56%, Camtek 7.05%, and Nova 7.87%. Nice rose 7.18%. Turnover was NIS 3.98B equities and NIS 5.18B bonds.

Related tickers